We use cookies for a better user experience. Read our Privacy Policy

I Agree

In-vitro Toxicology Testing Market

In-vitro Toxicology Testing Market by Method (Cellular Assay- Live Cells, Fixed Cells Biochemical Assay, In-Silico, and Ex-vivo), by Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, and OMICS Technology), by End-use, by Application and by Region - 2022 to 2032

Market Snapshot

Newly-released In-vitro Toxicology Testing market analysis report by Transparency Market Research shows that global sales of In-vitro Toxicology Testing market in 2021 was held at US$ 24.1 Bn. With 13%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth.

The absolute dollar opportunity for the In-vitro Toxicology Testing market is projected at US$ 64.3 Bn during the forecast period. One of the key market drivers is significant breakthroughs in toxicity science. Furthermore, the high costs associated with traditional animal tests as well as the socio-ethical considerations connected with animal experiments are expected to drive the expansion of the market for in-vitro toxicological testing.

Attribute

Details

Global In-vitro Toxicology Testing Market (2022)

US$ 27 Bn

Global In-vitro Toxicology Testing Market (2032)

US$ 91.3 Bn

Global In-vitro Toxicology Testing Market CAGR (2022 – 2032)

13%

U.S. In-vitro Toxicology Testing Market CAGR (2022 – 2032)

11.7%

Key Companies Profiled

  • Merck KGaA
  • Charles River
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • GE Healthcare
  • Quest Diagnostics Incorporated
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings
  • Evotec
  • Creative Bioarray
  • Gentronix
  • BioIVT
  • SGS SA
  • Agilent Technologies

Revenue of In-vitro Toxicology Testing Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the In-vitro Toxicology Testing market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the market increased at around 11.3% CAGR, wherein, North America held a significant share in the global market.

Early-stage adverse events discovered through in-vitro toxicity testing can help prevent serious adverse events throughout the majority of drug discovery projects, which is why the development of dozens of medicines projected to drive the market for in-vitro toxicity testing. Since November 2020, 590 drugs were under development in relation to coronavirus. A large number of drug development initiatives are expected to increase the demand for In-vitro Toxicology Testing services. As a result, the In-vitro Toxicology Testing market is expected to grow at a CAGR of 13% over the next ten years.

What will be the growth prospects of the In-vitro Toxicology Testing Market?

Significant improvements in in-vitro toxicology tests to evaluate medicinal product safety, as well as the evaluation of medicines' potential influence on cells and tissues, are expected to boost revenue creation in the market. With the increased need for such assays, firms have widened their offering to meet the demand for in-vitro toxicity testing. The availability of various tools in the biotechnology and bioinformatics divisions to do in-silico simulations on animal models is also affecting business growth. Furthermore, the growth of toxicology databases for the in-silico study of various chemicals is expected to drive demand for in-vitro procedures, resulting in industry propagation.

Significant government support for research, combined with specific reimbursement rules, is intended to improve market stability by developing automated and technologically sophisticated equipment for laboratory analysis and ex-vivo examinations. On the contrary, the lack of immunity testing and immune stimulation in present in-vitro tests is likely to stymie the industry's expansion.

Region-wise Analysis

Which Region is projected to Offer the Largest Opportunity for In-vitro Toxicology Testing Market?

North America has been a significant contributor to the In-Vitro Toxicology Testing Market revenues with a projected market of over US$ 36 Bn by 2032. The market in the region is expected to grow at a CAGR of over 11% during 2022 – 2032.

The ongoing introduction of biologics and biosimilar drugs by biopharmaceutical producers in the United States fuels demand for in-vitro toxicity testing in North America. Furthermore, government authorities are participating in drug discovery investment and funding projects. Some of the entities actively involved in investment in basic drug discovery research and improving the use of alternative modalities of toxicity testing in the United States are the National Institutes of Health and the Defense Advanced Research Projects Agency.

Region-wise Analysis

U.S. In-vitro Toxicology Testing Market Analysis

The US leads the global market, which is projected to reach US$ 32.4 billion by 2032 rising at a CAGR of 11.7% during the forecast period. In the United States, reimbursement and technical advancement facilities are positive considerations.

An increased emphasis on drug discovery by government bodies, an increase in healthcare expenditure, and the provision of suitable infrastructure for the growth and development of drug discovery technologies have been the key market drivers in the U.S. Furthermore, strict regulatory standards for medication development and approval have increased the use of in-vitro toxicity testing services in the market.

U.K. In-vitro Toxicology Testing Market Analysis

The market in the U.K. is expected to reach a valuation of US$ 4.2 Bn by 2032, growing at a CAGR of 16%. During 2022 – 2032, the market is projected to gross an absolute dollar opportunity of US$ 3.2 Bn.

Japan In-vitro Toxicology Testing Market Analysis

In Japan, the market is projected to be valued at US$ 3.2 Bn by 2032. The market in the country is expected to gross an absolute dollar opportunity of US$ 2.3 Bn during the forecast period, growing at a CAGR of 13.8%.

South Korea In-vitro Toxicology Testing Market Analysis

The market in South Korea is expected to be valued at US$ 2.2 Bn by 2032. The market is projected to gross an absolute dollar opportunity of US$ 1.6 Bn, growing at a CAGR of 14.6% during 2022 – 2032.

Category-wise Insights

Why Cellular Assays Capture Significant Demand in In-vitro Toxicology Testing Market?

Due to the rising drug discovery screening to detect cytotoxicity and other bio-chemicals, cellular assay compliance with the requirement specification segment dominated the market in 2021. The introduction of new products for testing cannabis-based pharmaceuticals is hastening the industry's expansion. The market through cellular assay will expand at a CAGR of 15.2% throughout the forecast period.

In the early phases of medication development, numerous pharmaceutical and biotech businesses rely heavily on cellular tests for toxicity screening. In-vitro cell viability tests provide various advantages, including low cost, quick results, and the opportunity for automation. These assays, however, present significant technical issues and are yet to totally replace animal testing, creating challenges to their expansion. The ex-vivo segment, on the other hand, is projected to increase at a rapid pace throughout the projection period.

Ex-vivo or tiny explant cultures allow drug screening tests to be carried out in a sterile, regulated, and dynamic environment while preserving the natural architecture of the tissues. The fact that the ex-vivo model performs tests or detections outside the organism is a significant benefit.

Competitive Analysis

Some of the key companies operating in the global In-vitro Toxicology Testing market include Merck KGaA, Charles River, Bio-Rad Laboratories, Inc., Abbott, Thermo Fisher Scientific Inc., Catalent, Inc., GE Healthcare, Quest Diagnostics Incorporated, Eurofins Scientific, Laboratory Corporation of America Holdings, Evotec, Creative Bioarray, Gentronix, BioIVT, SGS SA, and Agilent Technologies among others.

The recent developments in in-vitro toxicology testing market are:

  • In September 2019, Covance in Shanghai launched a new R&D center in China to strengthen its In-vitro Toxicology Testing business in Asia Pacific.
  • In August 2019, Abbott announced a deal with Intoximeters to market Abbott's SoToxa Mobile Test System, a portable oral fluid solution for alcohol and drug testing, in the United States. The product can detect amphetamine, benzodiazepines, cocaine, methamphetamine, opiates, and cannabis (THC).
  • In August 2019, Covance added an analytical laboratory feature to its functioning vendor (FSPx) offering along with clinical operations capacities and clinical analytics services.

Market Segments Covered in In-vitro Toxicology Testing Industry Analysis

By Method  

  • Cellular Assay
    • Live Cells
    • Fixed Cells
  • Biochemical Assay
  • In-Silico
  • Ex-vivo

By End-use

  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Academic Institutes and Research Laboratories
  • Diagnostics
  • Chemical Industry
  • Food Industry

By Technology

  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • OMICS Technology

By Application

  • Systemic Toxicology
  • Dermal Toxicity
  • Endocrine Disruption
  • Ocular Toxicity
  • Other Applications

By Region 

  • North America 
  • Latin America 
  • Europe 
  • APAC 
  • MEA 
In-vitro Toxicology Testing Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How much is the current worth of the In-vitro Toxicology Testing market?

The global market is worth more than US$ 27Bn at present.

What is the sales forecast for the In-vitro Toxicology Testing market?

The market value is projected to increase at a CAGR of around 13% during 2022 – 2032.

What was the last 5 year’s market CAGR?

The market value increased at a CAGR of around 11.3% during 2017 – 2021.

Which are the top 5 countries driving demand for In-vitro Toxicology Testing?

The top 5 countries driving demand for the In-vitro Toxicology Testing market are the U.S., China, the UK, Japan, and South Korea.

What is the key Method for the In-vitro Toxicology Testing market?

The key method having the highest demand is Cellular Assay which will be accounted for 15.2% CAGR during 2022-2032.

At what percentage is sales of In-vitro Toxicology Testing going to register growth in the US?

The US market for In-vitro Toxicology Testing is projected to expand at a CAGR of around 11.7% during 2022 – 2032.

Which are the key companies for In-vitro Toxicology Testing?

The key companies are Merck KGaA, Charles River, Bio-Rad Laboratories, Inc., Abbott, Thermo Fisher Scientific Inc., Catalent, Inc., GE Healthcare, Quest Diagnostics Incorporated, Eurofins Scientific, Laboratory Corporation of America Holdings, Evotec, Creative Bioarray, Gentronix, BioIVT, SGS SA, and Agilent Technologies among others.

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage

    2.2. Market Definition

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on In-vitro Toxicology Testing Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. In-vitro Toxicology Testing Market, by Key Countries

    4.2. In-vitro Toxicology Testing Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. In-vitro Toxicology Testing Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. In-vitro Toxicology Testing Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global In-vitro Toxicology Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2017-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global In-vitro Toxicology Testing Market Value Analysis 2017-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Method

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Method, 2017-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Method, 2022-2032

        8.3.1. Cellular Assay

            8.3.1.1. Live Cells

            8.3.1.2. Fixed Cells

        8.3.2. Biochemical Assay

        8.3.3. In-Silico

        8.3.4. Ex-vivo

    8.4. Market Attractiveness Analysis By Method

9. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End-use

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By End-use, 2017-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2022-2032

        9.3.1. Pharmaceutical Industry

        9.3.2. Cosmetics & Household Products

        9.3.3. Academic Institutes and Research Laboratories

        9.3.4. Diagnostics

        9.3.5. Chemical Industry

        9.3.6. Food Industry

    9.4. Market Attractiveness Analysis By End-use

10. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Technology

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Technology, 2017-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032

        10.3.1. Cell Culture Technology

        10.3.2. High Throughput Technology

        10.3.3. Molecular Imaging

        10.3.4. OMICS Technology

    10.4. Market Attractiveness Analysis By Technology

11. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Application

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Application, 2017-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032

        11.3.1. Systemic Toxicology

        11.3.2. Dermal Toxicity

        11.3.3. Endocrine Disruption

        11.3.4. Occular Toxicity

        11.3.5. Other Applications

    11.4. Market Attractiveness Analysis By Application

12. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021

    12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Asia Pacific

        12.3.5. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. U.S.

            13.4.1.2. Canada

            13.4.1.3. Rest of North America

        13.4.2. By Method

        13.4.3. By End-use

        13.4.4. By Application

        13.4.5. By Technology

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Method

        13.5.3. By End-use

        13.5.4. By Application

        13.5.5. By Technology

14. Latin America In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Brazil

            14.4.1.2. Mexico

            14.4.1.3. Rest of Latin America

        14.4.2. By Method

        14.4.3. By End-use

        14.4.4. By Application

        14.4.5. By Technology

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Method

        14.5.3. By End-use

        14.5.4. By Application

        14.5.5. By Technology

15. Europe In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. Germany

            15.4.1.2. France

            15.4.1.3. U.K.

            15.4.1.4. Italy

            15.4.1.5. Benelux

            15.4.1.6. Nordic Countries

            15.4.1.7. Rest of Europe

        15.4.2. By Method

        15.4.3. By End-use

        15.4.4. By Application

        15.4.5. By Technology

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Method

        15.5.3. By End-use

        15.5.4. By Application

        15.5.5. By Technology

16. Asia Pacific In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. China

            16.4.1.2. Japan

            16.4.1.3. South Korea

            16.4.1.4. Rest of Asia Pacific

        16.4.2. By Method

        16.4.3. By End-use

        16.4.4. By Application

        16.4.5. By Technology

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Method

        16.5.3. By End-use

        16.5.4. By Application

        16.5.5. By Technology

17. Middle East and Africa In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        17.4.1. By Country

            17.4.1.1. GCC Countries

            17.4.1.2. South Africa

            17.4.1.3. Turkey

            17.4.1.4. Rest of Middle East and Africa

        17.4.2. By Method

        17.4.3. By End-use

        17.4.4. By Application

        17.4.5. By Technology

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Method

        17.5.3. By End-use

        17.5.4. By Application

        17.5.5. By Technology

18. Key Countries In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. US In-vitro Toxicology Testing Market Analysis

        18.2.1. Value Proportion Analysis by Market Taxonomy

        18.2.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.2.2.1. By Method

            18.2.2.2. By End-use

            18.2.2.3. By Application

            18.2.2.4. By Technology

    18.3. Canada In-vitro Toxicology Testing Market Analysis

        18.3.1. Value Proportion Analysis by Market Taxonomy

        18.3.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.3.2.1. By Method

            18.3.2.2. By End-use

            18.3.2.3. By Application

            18.3.2.4. By Technology

    18.4. Mexico In-vitro Toxicology Testing Market Analysis

        18.4.1. Value Proportion Analysis by Market Taxonomy

        18.4.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.4.2.1. By Method

            18.4.2.2. By End-use

            18.4.2.3. By Application

            18.4.2.4. By Technology

    18.5. Brazil In-vitro Toxicology Testing Market Analysis

        18.5.1. Value Proportion Analysis by Market Taxonomy

        18.5.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.5.2.1. By Method

            18.5.2.2. By End-use

            18.5.2.3. By Application

            18.5.2.4. By Technology

    18.6. Germany In-vitro Toxicology Testing Market Analysis

        18.6.1. Value Proportion Analysis by Market Taxonomy

        18.6.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.6.2.1. By Method

            18.6.2.2. By End-use

            18.6.2.3. By Application

            18.6.2.4. By Technology

    18.7. France In-vitro Toxicology Testing Market Analysis

        18.7.1. Value Proportion Analysis by Market Taxonomy

        18.7.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.7.2.1. By Method

            18.7.2.2. By End-use

            18.7.2.3. By Application

            18.7.2.4. By Technology

    18.8. Italy In-vitro Toxicology Testing Market Analysis

        18.8.1. Value Proportion Analysis by Market Taxonomy

        18.8.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.8.2.1. By Method

            18.8.2.2. By End-use

            18.8.2.3. By Application

            18.8.2.4. By Technology

    18.9. BENELUX In-vitro Toxicology Testing Market Analysis

        18.9.1. Value Proportion Analysis by Market Taxonomy

        18.9.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.9.2.1. By Method

            18.9.2.2. By End-use

            18.9.2.3. By Application

            18.9.2.4. By Technology

    18.10. UK In-vitro Toxicology Testing Market Analysis

        18.10.1. Value Proportion Analysis by Market Taxonomy

        18.10.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.10.2.1. By Method

            18.10.2.2. By End-use

            18.10.2.3. By Application

            18.10.2.4. By Technology

    18.11. Nordic Countries In-vitro Toxicology Testing Market Analysis

        18.11.1. Value Proportion Analysis by Market Taxonomy

        18.11.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.11.2.1. By Method

            18.11.2.2. By End-use

            18.11.2.3. By Application

            18.11.2.4. By Technology

    18.12. China In-vitro Toxicology Testing Market Analysis

        18.12.1. Value Proportion Analysis by Market Taxonomy

        18.12.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.12.2.1. By Method

            18.12.2.2. By End-use

            18.12.2.3. By Application

            18.12.2.4. By Technology

    18.13. Japan In-vitro Toxicology Testing Market Analysis

        18.13.1. Value Proportion Analysis by Market Taxonomy

        18.13.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.13.2.1. By Method

            18.13.2.2. By End-use

            18.13.2.3. By Application

            18.13.2.4. By Technology

    18.14. South Korea In-vitro Toxicology Testing Market Analysis

        18.14.1. Value Proportion Analysis by Market Taxonomy

        18.14.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.14.2.1. By Method

            18.14.2.2. By End-use

            18.14.2.3. By Application

            18.14.2.4. By Technology

    18.15. GCC Countries In-vitro Toxicology Testing Market Analysis

        18.15.1. Value Proportion Analysis by Market Taxonomy

        18.15.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.15.2.1. By Method

            18.15.2.2. By End-use

            18.15.2.3. By Application

            18.15.2.4. By Technology

    18.16. South Africa In-vitro Toxicology Testing Market Analysis

        18.16.1. Value Proportion Analysis by Market Taxonomy

        18.16.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.16.2.1. By Method

            18.16.2.2. By End-use

            18.16.2.3. By Application

            18.16.2.4. By Technology

    18.17. Turkey In-vitro Toxicology Testing Market Analysis

        18.17.1. Value Proportion Analysis by Market Taxonomy

        18.17.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.17.2.1. By Method

            18.17.2.2. By End-use

            18.17.2.3. By Application

            18.17.2.4. By Technology

        18.17.3. Competition Landscape and Player Concentration in the Country

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

        19.4.1. By Regional footprint of Players

        19.4.2. Product footprint by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. MERCK KGAA

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Sales Footprint

            20.3.1.4. Strategy Overview

        20.3.2. CHARLES RIVER

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Sales Footprint

            20.3.2.4. Strategy Overview

        20.3.3. BIO-RAD LABORATORIES, INC.

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Sales Footprint

            20.3.3.4. Strategy Overview

        20.3.4. ABBOTT

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Sales Footprint

            20.3.4.4. Strategy Overview

        20.3.5. THERMO FISHER SCIENTIFIC INC.

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Sales Footprint

            20.3.5.4. Strategy Overview

        20.3.6. CATALENT, INC.

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Sales Footprint

            20.3.6.4. Strategy Overview

        20.3.7. GE HEALTHCARE

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Sales Footprint

            20.3.7.4. Strategy Overview

        20.3.8. QUEST DIAGNOSTICS INCORPORATED

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Sales Footprint

            20.3.8.4. Strategy Overview

        20.3.9. EUROFINS SCIENTIFIC

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Sales Footprint

            20.3.9.4. Strategy Overview

        20.3.10. LABORATORY CORPORATION OF AMERICA HOLDINGS

            20.3.10.1. Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Sales Footprint

            20.3.10.4. Strategy Overview

        20.3.11. EVOTEC

            20.3.11.1. Overview

            20.3.11.2. Product Portfolio

            20.3.11.3. Sales Footprint

            20.3.11.4. Strategy Overview

        20.3.12. CREATIVE BIOARRAY

            20.3.12.1. Overview

            20.3.12.2. Product Portfolio

            20.3.12.3. Sales Footprint

            20.3.12.4. Strategy Overview

        20.3.13. GENTRONIX

            20.3.13.1. Overview

            20.3.13.2. Product Portfolio

            20.3.13.3. Sales Footprint

            20.3.13.4. Strategy Overview

        20.3.14. BIOIVT

            20.3.14.1. Overview

            20.3.14.2. Product Portfolio

            20.3.14.3. Sales Footprint

            20.3.14.4. Strategy Overview

        20.3.15. SGS SA

            20.3.15.1. Overview

            20.3.15.2. Product Portfolio

            20.3.15.3. Sales Footprint

            20.3.15.4. Strategy Overview

        20.3.16. AGILENT TECHNOLOGIES

            20.3.16.1. Overview

            20.3.16.2. Product Portfolio

            20.3.16.3. Sales Footprint

            20.3.16.4. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

List of Tables

Table 1: Global In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021

Table 2: Global In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032

Table 3: Global In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021

Table 4: Global In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032

Table 5: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021

Table 6: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032

Table 7: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021

Table 8: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032

Table 9: Global In-vitro Toxicology Testing Market, By Region, 2017 – 2021

Table 10: Global In-vitro Toxicology Testing Market, By Region, 2022 – 2032

Table 11: North America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021

Table 12: North America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032

Table 13: North America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021

Table 14: North America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032

Table 15: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021

Table 16: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032

Table 17: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021

Table 18: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032

Table 19: North America In-vitro Toxicology Testing Market, By Country, 2017 – 2021

Table 20: North America In-vitro Toxicology Testing Market, By Country, 2022 – 2032

Table 21: Latin America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021

Table 22: Latin America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032

Table 23: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021

Table 24: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032

Table 25: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021

Table 26: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032

Table 27: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021

Table 28: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032

Table 29: Latin America In-vitro Toxicology Testing Market, By Country, 2017 – 2021

Table 30: Latin America In-vitro Toxicology Testing Market, By Country, 2022 – 2032

Table 31: Europe In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021

Table 32: Europe In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032

Table 33: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021

Table 34: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032

Table 35: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021

Table 36: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032

Table 37: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021

Table 38: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032

Table 39: Europe In-vitro Toxicology Testing Market, By Country, 2017 – 2021

Table 40: Europe In-vitro Toxicology Testing Market, By Country, 2022 – 2032

Table 41: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021

Table 42: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032

Table 43: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021

Table 44: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032

Table 45: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021

Table 46: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032

Table 47: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021

Table 48: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032

Table 49: Asia Pacific In-vitro Toxicology Testing Market, By Country, 2017 – 2021

Table 50: Asia Pacific In-vitro Toxicology Testing Market, By Country, 2022 – 2032

Table 51: MEA In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021

Table 52: MEA In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032

Table 53: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021

Table 54: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032

Table 55: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021

Table 56: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032

Table 57: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021

Table 58: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032

Table 59: MEA In-vitro Toxicology Testing Market, By Country, 2017 – 2021

Table 60: MEA In-vitro Toxicology Testing Market, By Country, 2022 – 2032

List of Figures

Figure 1: Global In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

Figure 2: Global In-vitro Toxicology Testing Market Absolute $ Historical Gain (2017 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032

Figure 4: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method – 2022-2032

Figure 5: Global In-vitro Toxicology Testing Market Attractiveness Index, By Method – 2022-2032

Figure 6: Global In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032

Figure 7: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use – 2022-2032

Figure 8: Global In-vitro Toxicology Testing Market Attractiveness Index, By End-use – 2022-2032

Figure 9: Global In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032

Figure 10: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 11: Global In-vitro Toxicology Testing Market Attractiveness Index, By Application – 2022-2032

Figure 12: Global In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032

Figure 13: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 14: Global In-vitro Toxicology Testing Market Attractiveness Index, By Technology – 2022-2032

Figure 15: Global In-vitro Toxicology Testing Market Share, By Region, 2022 & 2032

Figure 16: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 17: Global In-vitro Toxicology Testing Market Attractiveness Index, By Region – 2022-2032

Figure 18: North America In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

Figure 19: North America In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 20: North America In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032

Figure 21: North America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method – 2022-2032

Figure 22: North America In-vitro Toxicology Testing Market Attractiveness Index, By Method – 2022-2032

Figure 23: North America In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032

Figure 24: North America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use – 2022-2032

Figure 25: North America In-vitro Toxicology Testing Market Attractiveness Index, By End-use – 2022-2032

Figure 26: North America In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032

Figure 27: North America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 28: North America In-vitro Toxicology Testing Market Attractiveness Index, By Application – 2022-2032

Figure 29: North America In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032

Figure 30: North America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 31: North America In-vitro Toxicology Testing Market Attractiveness Index, By Technology – 2022-2032

Figure 32: North America In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032

Figure 33: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 34: North America Market Attractiveness Index, By Country – 2022-2032

Figure 35: Latin America In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

Figure 36: Latin America In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 37: Latin America In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032

Figure 38: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method – 2022-2032

Figure 39: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By Method – 2022-2032

Figure 40: Latin America In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032

Figure 41: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use – 2022-2032

Figure 42: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By End-use – 2022-2032

Figure 43: Latin America In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032

Figure 44: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 45: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By Application – 2022-2032

Figure 46: Latin America In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032

Figure 47: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 48: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By Technology – 2022-2032

Figure 49: Latin America In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032

Figure 50: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 51: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By Country – 2022-2032

Figure 52: Europe In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

Figure 53: Europe In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 54: Europe In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032

Figure 55: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method – 2022-2032

Figure 56: Europe In-vitro Toxicology Testing Market Attractiveness Index, By Method – 2022-2032

Figure 57: Europe In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032

Figure 58: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use – 2022-2032

Figure 59: Europe In-vitro Toxicology Testing Market Attractiveness Index, By End-use – 2022-2032

Figure 60: Europe In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032

Figure 61: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 62: Europe In-vitro Toxicology Testing Market Attractiveness Index, By Application – 2022-2032

Figure 63: Europe In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032

Figure 64: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 65: Europe In-vitro Toxicology Testing Market Attractiveness Index, By Technology – 2022-2032

Figure 66: Europe In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032

Figure 67: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 68: Europe In-vitro Toxicology Testing Market Attractiveness Index, By Country – 2022-2032

Figure 69: MEA In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

Figure 70: MEA In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 71: MEA In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032

Figure 72: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method – 2022-2032

Figure 73: MEA In-vitro Toxicology Testing Market Attractiveness Index, By Method – 2022-2032

Figure 74: MEA In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032

Figure 75: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use – 2022-2032

Figure 76: MEA In-vitro Toxicology Testing Market Attractiveness Index, By End-use – 2022-2032

Figure 77: MEA In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032

Figure 78: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 79: MEA In-vitro Toxicology Testing Market Attractiveness Index, By Application – 2022-2032

Figure 80: MEA In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032

Figure 81: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 82: MEA In-vitro Toxicology Testing Market Attractiveness Index, By Technology – 2022-2032

Figure 83: MEA In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032

Figure 84: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 85: MEA In-vitro Toxicology Testing Market Attractiveness Index, By Country – 2022-2032

Figure 86: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

Figure 87: Asia Pacific In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 88: Asia Pacific In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032

Figure 89: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method – 2022-2032

Figure 90: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By Method – 2022-2032

Figure 91: Asia Pacific In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032

Figure 92: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use – 2022-2032

Figure 93: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By End-use – 2022-2032

Figure 94: Asia Pacific In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032

Figure 95: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 96: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By Application – 2022-2032

Figure 97: Asia Pacific In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032

Figure 98: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 99: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By Technology – 2022-2032

Figure 100: Asia Pacific In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032

Figure 101: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 102: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By Country – 2022-2032

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

307

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved